Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Bangladesh Health Times.
Gildan Reports Record Second Quarter Revenue and Adjusted Diluted EPS¹ and Updates its Full Year 2025 Guidance
GlobeNewswire, Inc.
·
July 31, 2025
(all amounts are in U.S. dollars except where otherwise indicated) (1) Please refer to "Non-GAAP financial measures and related ratios" in this press release Record net sales of $919 million, up 6.5% vs. the prior year Operating margin of 21.7%,...
IRSA: Lighting Up the Future, Connecting the World Yarlung Tsangpo Hydropower Project Breaks Ground, Marking a New Pinnacle in China’s Mega Infrastructure
GlobeNewswire, Inc.
·
July 30, 2025
New York, July 30, 2025 (GLOBE NEWSWIRE) -- According to International Relations Study Association(IRSA), on July 19, 2025, in Motuo County, a remote border town in Nyingchi, Tibet Autonomous Region of China, a single blast announced a feat...
AV Global Overseas Launches New Initiatives to Empower Indian Students for Study Abroad Success
EIN Presswire
·
June 13, 2025
Leading education consultancy unveils expanded counseling, test prep, and scholarships for Indian students planning to study MBBS abroad. MUMBAI, MAHARASHTRA, INDIA, June 13, 2025 /EINPresswire.com/ -- AV Global Overseas, a trusted overseas...
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
May 5, 2025
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all...
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
May 5, 2025
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all...
Minister John Steenhuisen: RSA Group Stakeholder Dinner
South African Government
·
July 25, 2025
Ladies and gentlemen, esteemed members of the fresh produce industry, friends and partners, It is an honour to join you tonight at this RSA Group Stakeholder Dinner. I want to thank the organisers for bringing together such a crucial mass of...
Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
GlobeNewswire, Inc.
·
May 7, 2025
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to...
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
GlobeNewswire, Inc.
·
March 27, 2025
REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
In-Depth Analysis Of The Global Sign Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034
EIN Presswire
·
June 5, 2025
The Business Research Company’s Sign Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2025 /EINPresswire.com/ -- What Is The Projected Market Size Of The Sign Market? From...
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
GlobeNewswire, Inc.
·
March 20, 2025
REYKJAVIK, Iceland and STOCKHOLM, March 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition...
![[Latest] Global Caustic Soda Flakes Market Size/Share Worth USD 16.81 Billion by 2034 at a 3.20% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/21273967-731329129-cmi-logo-png-100x51.png){kind=logo}
[Latest] Global Caustic Soda Flakes Market Size/Share Worth USD 16.81 Billion by 2034 at a 3.20% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire, Inc.
·
July 3, 2025
Austin, TX, USA, July 03, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Caustic Soda Flakes Market Size, Trends and Insights By Application (Alumina Refining, Pulp and Paper Processing, Textile...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
February 18, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
February 18, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
GlobeNewswire, Inc.
·
December 8, 2024
In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest Dose Level Explored to Date Achieved 36 Percent Overall Response Rate (ORR) and 45 Percent Clinical Benefit Rate (CBR); Responses Seen Across All Dose Levels Multiple...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
GlobeNewswire, Inc.
·
January 27, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
GlobeNewswire, Inc.
·
January 27, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Stainless Steel World Asia Expo 2024: YOUFA GROUP Exhibits Steel Pipe Innovations
EIN Presswire
·
July 7, 2025
TIANJIN, TIANJIN, CHINA, July 7, 2025 /EINPresswire.com/ -- The Stainless Steel World Asia Conference & Expo 2024, which took place from September 25-27, 2024, at the prestigious Shanghai New International Expo Centre in Shanghai, China, served...
Alvotech Reports Record Results for 2024 and Provides Business Update
GlobeNewswire, Inc.
·
March 26, 2025
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior year Product Revenues in 2024 reached $273 million, representing a 462% increase over prior year Adjusted EBITDA in 2024 was $108.3 million compared to negative...
Shaip Overhauls Its Own AI Workforce with Airtm with Faster Pay, Higher Retention, Fairer Access
EIN Presswire
·
July 8, 2025
DOVER, DE, UNITED STATES, July 8, 2025 /EINPresswire.com/ -- Airtm, the leading payment and contributor platform empowering digital workers in the Global South, announced a strategic new partnership with Shaip, a data-centric AI solutions...
Patient Monitoring and Ultrasound Devices Display Market Projected to Exceed USD 10.6 Billion by 2034 | TMR
EIN Presswire
·
December 20, 2024
The market for patient monitoring and ultrasound devices display is growing with advancements in real-time health monitoring and diagnostics WILMINGTON, DE, UNITED STATES, December 21, 2024 /EINPresswire.com/ -- The global patient monitoring and...